Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
1.790
+0.030 (1.70%)
At close: Aug 14, 2026, 4:00 PM EDT
1.790
0.00 (0.01%)
After-hours: Aug 14, 2026, 7:59 PM EDT

Organogenesis Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-84.1637.030.864.9515.5394.2
Depreciation & Amortization
18.818.617.0315.3710.7316.68
Loss (Gain) From Sale of Assets
2.2111.361.140.244.481.41
Asset Writedown & Restructuring Costs
4.92-22.8---
Stock-Based Compensation
14.0813.310.5896.553.86
Provision & Write-off of Bad Debts
2.128.213.941.31.783
Other Operating Activities
68.9333.576.7518.1519.87-20.16
Change in Accounts Receivable
17.32-115.8-31.85.54-8.77-28.65
Change in Inventory
-13.84-17.92-6.2-8.18-9.41-9.3
Change in Accounts Payable
-3.56-0.53-2.37-0.113.263.85
Change in Other Net Operating Assets
5.151.87-8.51-15.33-19.16-2.9
Operating Cash Flow
31.97-10.3114.2130.9224.8661.98
Operating Cash Flow Growth
---54.05%24.37%-59.89%1033.88%
Capital Expenditures
-11.13-14.15-10.03-24.36-33.9-31.22
Investing Cash Flow
-11.13-14.15-10.03-24.36-33.9-31.22
Long-Term Debt Issued
-----73.17
Long-Term Debt Repaid
--1.17-67.64-5.17-3.01-75.19
Net Debt Issued (Repaid)
-10.79-1.17-67.64-5.17-3.01-2.01
Issuance of Common Stock
0.130.161.25-2.072.2
Repurchase of Common Stock
-3.14-1.89-26.65-0.33-0.65-0.74
Other Financing Activities
-33.94-14.46---0.61-0.48
Financing Cash Flow
-47.73-17.3627.64-5.51-2.2-1.04
Net Cash Flow
-26.89-41.8231.811.05-11.2429.72
Free Cash Flow
20.84-24.464.186.55-9.0430.76
Free Cash Flow Growth
---36.27%---
Free Cash Flow Margin
4.56%-4.34%0.87%1.51%-2.00%6.58%
Free Cash Flow Per Share
0.16-0.190.030.05-0.070.23
Levered Free Cash Flow
28.45-46.8610.2210.79-17.3823.45
Unlevered Free Cash Flow
28.45-46.8611.1812.16-16.1327.97
Cash Interest Paid
--4.975.442.655.79
Cash Income Tax Paid
5.355.356.973.051.20.61
Change in Working Capital
5.07-132.38-48.89-18.07-34.08-37.01
SEC Filings: 10-K · 10-Q